CN113274364A - 雷美替胺缓释制剂及其制备方法 - Google Patents
雷美替胺缓释制剂及其制备方法 Download PDFInfo
- Publication number
- CN113274364A CN113274364A CN202110833011.8A CN202110833011A CN113274364A CN 113274364 A CN113274364 A CN 113274364A CN 202110833011 A CN202110833011 A CN 202110833011A CN 113274364 A CN113274364 A CN 113274364A
- Authority
- CN
- China
- Prior art keywords
- ramelteon
- sustained
- parts
- release
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110833011.8A CN113274364B (zh) | 2021-07-22 | 2021-07-22 | 雷美替胺缓释制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110833011.8A CN113274364B (zh) | 2021-07-22 | 2021-07-22 | 雷美替胺缓释制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113274364A true CN113274364A (zh) | 2021-08-20 |
CN113274364B CN113274364B (zh) | 2021-12-07 |
Family
ID=77286974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110833011.8A Active CN113274364B (zh) | 2021-07-22 | 2021-07-22 | 雷美替胺缓释制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113274364B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533699A (zh) * | 2021-12-15 | 2022-05-27 | 南通联亚药业股份有限公司 | 一种盐酸环苯扎林缓释胶囊及其制备方法 |
CN115708820A (zh) * | 2023-01-09 | 2023-02-24 | 广东科泰鼎润药业科技有限公司 | L-茶氨酸缓释制剂、双释放制剂、应用和药物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007517040A (ja) * | 2003-12-24 | 2007-06-28 | セプレイコー インコーポレイテッド | 睡眠の質を改善するためのメラトニン併用療法 |
CN102018681A (zh) * | 2010-12-10 | 2011-04-20 | 荣港生技医药科技(北京)有限公司 | 一种美乐托宁缓释剂、其制备方法及其应用 |
CN103394087A (zh) * | 2004-10-28 | 2013-11-20 | 雅戈泰克股份公司 | 治疗失眠的药物的时间延迟剂型 |
US20160067186A1 (en) * | 2011-01-28 | 2016-03-10 | Zx Pharma, Llc | Controlled-Release Melatonin Compositions and Related Methods |
CN110433142A (zh) * | 2019-09-06 | 2019-11-12 | 杭州百诚医药科技股份有限公司 | 一种雷美替胺舌下片及其制备方法 |
-
2021
- 2021-07-22 CN CN202110833011.8A patent/CN113274364B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007517040A (ja) * | 2003-12-24 | 2007-06-28 | セプレイコー インコーポレイテッド | 睡眠の質を改善するためのメラトニン併用療法 |
CN103394087A (zh) * | 2004-10-28 | 2013-11-20 | 雅戈泰克股份公司 | 治疗失眠的药物的时间延迟剂型 |
CN102018681A (zh) * | 2010-12-10 | 2011-04-20 | 荣港生技医药科技(北京)有限公司 | 一种美乐托宁缓释剂、其制备方法及其应用 |
US20160067186A1 (en) * | 2011-01-28 | 2016-03-10 | Zx Pharma, Llc | Controlled-Release Melatonin Compositions and Related Methods |
US20170128419A1 (en) * | 2011-01-28 | 2017-05-11 | Physician's Seal, LLC | Controlled-Release Melatonin Compositions and Related Methods |
CN110433142A (zh) * | 2019-09-06 | 2019-11-12 | 杭州百诚医药科技股份有限公司 | 一种雷美替胺舌下片及其制备方法 |
Non-Patent Citations (2)
Title |
---|
SEITHIKURIPPU R: "Ramelteon: a Review of its Therapeutic Potential in Sleep Disorders", 《ADV THER》 * |
毛万祥等: "人工神经网络辅助设计褪黑素缓释片处方", 《药学与临床研究》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533699A (zh) * | 2021-12-15 | 2022-05-27 | 南通联亚药业股份有限公司 | 一种盐酸环苯扎林缓释胶囊及其制备方法 |
CN115708820A (zh) * | 2023-01-09 | 2023-02-24 | 广东科泰鼎润药业科技有限公司 | L-茶氨酸缓释制剂、双释放制剂、应用和药物 |
Also Published As
Publication number | Publication date |
---|---|
CN113274364B (zh) | 2021-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2301537T3 (es) | Comprimidos y formulacion de guaifenesina de liberacion sostenida. | |
CN113274364B (zh) | 雷美替胺缓释制剂及其制备方法 | |
JPH10194969A (ja) | 錠剤組成物 | |
CN106413717A (zh) | 药物组合物 | |
TW200825107A (en) | Low-substituted hydroxypropylcellulose powder and method for producing the same | |
CN105142618A (zh) | 提供药理及临床效应的莫沙必利每日单次施用缓释制剂 | |
CN110559269A (zh) | 一种单硝酸异山梨酯片剂及其质量检测方法 | |
CN102218050A (zh) | 一种治疗抑郁症的药物组合物 | |
CN102949377B (zh) | 乙酰唑胺缓释胶囊及其制备方法 | |
BG65322B1 (bg) | Орални състави за агонисти или антагонисти на 5-ht долу 4 | |
KR20140019445A (ko) | 호흡기 질환에 작용하는 복합 화학 약물, 그들의 제조 방법 및 용도 | |
CN112426408B (zh) | 一种褪黑素组合物及其制备工艺 | |
CN101461788A (zh) | 一种间苯三酚口腔崩解片及其制备方法 | |
CN113274365B (zh) | 雷美替胺速释缓释双释放制剂及其制备方法 | |
CN109152740A (zh) | 一种马吲哚即释/缓释多层片剂及其在治疗注意力缺失/多动障碍(adhd)中的用途 | |
CN102218040A (zh) | 一种阿立哌唑组合物微晶的口腔崩解片及其制备方法 | |
CN109589314A (zh) | 含有氢溴酸沃替西汀口崩片的制备方法 | |
IL292492A (en) | Liquid formulations of tazimalthion and methods of using them | |
CN106880611A (zh) | 一种含微粉化的托伐普坦和水溶性辅料的托伐普坦制剂 | |
CN109157527B (zh) | 一种厄贝沙坦胶囊及其制备方法 | |
CN114272219B (zh) | 一种盐酸多奈哌齐片及其制备方法 | |
PT85880B (pt) | Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose | |
CN102552107B (zh) | 含唑吡坦或其盐的双相释放制剂及其制备方法 | |
CN113018271B (zh) | 一种坦度螺酮药物组合物及其制备方法和用途 | |
CN101375852B (zh) | 富马酸喹硫平口服制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211112 Address after: 570203 No. 16, Shunda Road, Meilan District, Haikou City, Hainan Province Applicant after: HAINAN HG PHARMACEUTICAL CO.,LTD. Address before: 510000 room B08, building 501, No. 1, Nanxiang Second Road, high tech Industrial Development Zone, Guangzhou, Guangdong Applicant before: Guangdong Ketai dingrun Pharmaceutical Technology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221024 Address after: 510000 room B08, building 501, No. 1, Nanxiang Second Road, high tech Industrial Development Zone, Guangzhou, Guangdong Patentee after: Guangdong Ketai dingrun Pharmaceutical Technology Co.,Ltd. Address before: No.16, Shunda Road, Meilan District, Haikou City, Hainan Province, 570203 Patentee before: HAINAN HG PHARMACEUTICAL CO.,LTD. |
|
TR01 | Transfer of patent right |